ClinicalTrials.Veeva

Menu

Efficacy Comparison Between Primary Care Physicians' Independent Auscultation and AI-assisted Auscultation for Congenital Heart Disease Screening in Patient-enriched Populations: a Randomized Controlled Trial

K

Kun Sun

Status

Enrolling

Conditions

Randomised Controlled Trial
Auscultation for Clinical Evaluation
Screening Tool
Artifical Intelligence
Congenital Heart Disease (CHD)

Treatments

Diagnostic Test: Independent auscultation
Diagnostic Test: AI-assisted auscultation

Study type

Interventional

Funder types

Other

Identifiers

NCT06791096
INV-072724 (Other Grant/Funding Number)
XHEC-C-2025-012-1

Details and patient eligibility

About

In recent years, the application of artificial intelligence (AI) in the healthcare domain has witnessed a significant surge, with deep learning emerging as a potent force in the medical field. Deep learning algorithms possess the remarkable ability to automatically extract intricate features and patterns, thereby facilitating highly accurate heart sound recognition. Drawing on this technological advancement, Professor Sun Kun and his research team from Xinhua Hospital, in collaboration with numerous centers spanning across China, have been diligently investigating the development and application of AI-assisted heart sound recognition for congenital heart disease (CHD) screening.

Utilizing electronic stethoscopes to meticulously collect heart sounds, and harnessing AI algorithms to analyze extensive datasets comprising heart sounds from both children diagnosed with CHD and those who are healthy, the system has been trained to adeptly differentiate between normal and pathological murmurs. The current iteration of the system boasts an impressive accuracy and sensitivity rate of 90%.

This study is designed as a randomized controlled trial (RCT) to be conducted at Shanghai Xinhua Hospital and Qinghai Provincial Women and Children's Hospital. The primary objective is to demonstrate the superiority of AI-assisted primary care physicians in identifying CHD over primary care physicians working independently. This will be achieved by conducting a comparative analysis of the performance of AI-assisted physicians versus their unassisted counterparts, thereby substantiating the model's practical applicability. Through an ongoing process of refinement and widespread application, this pioneering research endeavors to empower a diverse range of medical professionals, including general practitioners, child health physicians, and non-cardiovascular specialists, with the transformative capabilities of AI-assisted electronic auscultation. The ultimate goal is to elevate the standard of pediatric care across the nation.

Enrollment

420 estimated patients

Sex

All

Ages

Under 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age between 0 to 18 years, with no gender restrictions.
  • Children who consent to undergo echocardiography to determine the presence or absence of congenital heart disease.
  • Voluntary participation in this study and signing of an informed consent form.

Exclusion criteria

  • Age greater than 18 years.
  • Children who are unable to undergo echocardiography or who do not cooperate with auscultation.
  • Participants who cannot provide informed consent or are unwilling to comply with study requirements to provide medical data for further analysis and research.

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

420 participants in 2 patient groups

Independent auscultation
Active Comparator group
Treatment:
Diagnostic Test: Independent auscultation
AI-assisted auscultation
Experimental group
Treatment:
Diagnostic Test: AI-assisted auscultation

Trial contacts and locations

2

Loading...

Central trial contact

Kun Sun, Phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems